相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J. L. Heerspink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effect of SGLT2 inhibitors on body composition, fluid status and renin-angiotensin-aldosterone system in type 2 diabetes: a prospective study using bioimpedance spectroscopy
Anja Schork et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
J. J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Diabetic kidney diseases revisited: A new perspective for a new era
Haiyan Fu et al.
MOLECULAR METABOLISM (2019)
Cardioprotective Potential of an SGLT2 Inhibitor Against Doxorubicin-Induced Heart Failure
Chang-Myung Oh et al.
KOREAN CIRCULATION JOURNAL (2019)
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review
Subodh Verma et al.
DIABETOLOGIA (2018)
Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy
Thomas H. Marwick et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk Observations From the SAVOR-TIMI 53 Trial
Benjamin M. Scirica et al.
JAMA CARDIOLOGY (2018)
Trends and Disparities in Cardiovascular Mortality Among US Adults With and Without Self-Reported Diabetes, 1988-2015
Yiling J. Cheng et al.
DIABETES CARE (2018)
Cardiac and Renal Effects of Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetes
Thomas A. Zelniker et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease
Guanghong Jia et al.
DIABETOLOGIA (2018)
Cardiac effects of SGLT2 inhibitors: the sodium hypothesis
Edoardo Bertero et al.
CARDIOVASCULAR RESEARCH (2018)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics
Patrycja Puchalska et al.
CELL METABOLISM (2017)
SGLT2 Inhibitors and the Diabetic Kidney
Paola Fioretto et al.
DIABETES CARE (2016)
CV Protection in the EMPA-REG OUTCOME Trial: A Thrifty Substrate Hypothesis
Ele Ferrannini et al.
DIABETES CARE (2016)
Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure
Isabelle Johansson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Heart failure and kidney dysfunction: epidemiology, mechanisms and management
Joerg C. Schefold et al.
NATURE REVIEWS NEPHROLOGY (2016)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Impact of Diabetes on Epidemiology, Treatment, and Outcomes of Patients With Heart Failure
Alessandra Dei Cas et al.
JACC-HEART FAILURE (2015)
How the kidney hyperfiltrates in diabetes: From molecules to hemodynamics
Tsuneo Takenaka et al.
WORLD JOURNAL OF DIABETES (2015)
Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling
Rebecca C. Schugar et al.
MOLECULAR METABOLISM (2014)
Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies
Stuart J. Pocock et al.
EUROPEAN HEART JOURNAL (2013)
Diabetic nephropathy: diagnosis and treatment
Daniel Fineberg et al.
NATURE REVIEWS ENDOCRINOLOGY (2013)
Health-related quality of life of patients with severe heart failure. A cross-sectional multicentre study
Nikolaos V. Fotos et al.
SCANDINAVIAN JOURNAL OF CARING SCIENCES (2013)
Importance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart Failure
Wilfried Mullens et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
Anushka Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Heart failure in the twenty-first century: Is it a coronary artery disease or hypertension problem?
Raghava S. Velagaleti et al.
CARDIOLOGY CLINICS (2007)